Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
18 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250618633082/en/Coya-Therapeutics-to-Present-at-the-iAccess-Alpha-Virtual-Best-Ideas-Summer-Conference-on-June-24-25-2025
02 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250602775188/en/Coya-Therapeutics-Announces-Issuance-of-New-U.S.-Patent-Protecting-Methods-of-Producing-Recombinant-Human-rh-Interleukin-2-aldesleukin-Liquid-Formulations
16 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250516024813/en/Coya-Therapeutics-to-Participate-at-the-H.C.-Wainwright-3rd-Annual-BioConnect-Investor-Conference
13 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250513705163/en/Coya-Therapeutics-Reports-First-Quarter-Financial-Results-and-Provides-a-Corporate-Update
08 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250508864726/en/Coya-Therapeutics-to-Participate-in-Two-Upcoming-Conferences-in-May-2025
24 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250424949204/en/Coya-Therapeutics-Announces-Positive-Interim-Results-of-an-Investigator-Initiated-Open-Label-Study-with-Low-Dose-IL-2-and-CTLA4-Ig-Combination-Treatment-in-Five-Patients-with-Mild-to-Moderate-Frontotemporal-Dementia
ABOUT THIS PAGE